Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.2 SEK | -0.31% | -1.34% | +24.19% |
May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.19% | 61.23M | |
+7.91% | 72.81B | |
+12.72% | 9.13B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
+20.00% | 2.42B | |
-26.13% | 2.32B | |
+19.31% | 2.17B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Transcript : Orexo AB, Q1 2021 Earnings Call, Apr 29, 2021